Aspirin plus ticagrelor or clopidogrel on graft patency one year after coronary bypass grafting: a single-center, randomized, controlled trial

CONCLUSIONS: Either aspirin plus ticagrelor or aspirin plus clopidogrel can maintain a fairly high graft patency rate in the early phase after CABG, regardless of CYP2C19 genotypes.PMID:33841960 | PMC:PMC8024791 | DOI:10.21037/jtd-20-3407
Source: Journal of Thoracic Disease - Category: Respiratory Medicine Authors: Source Type: research